Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Revent Medical developed the "ReVENT Sleep Apnea System," a minimally invasive implantable device designed to treat obstructive sleep apnea by preventing tongue base closure during sleep. The system underwent at least one post-market multicenter observational clinical trial, which was terminated. Preclinical safety and design assessments were published in peer-reviewed literature[1].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Revent Medical.